Literature DB >> 25252522

Attribution of lifestyle risk factors in subjects with and without impaired fasting glucose.

Mehran Babanejad, Farid Najafi, Amir Hossein Hashemian, Eskandar Gholami Parizad, Ali Delpisheh, Khairollah Asadollahi.   

Abstract

OBJECTIVE: To investigate the association between lifestyle risk factors and impaired fasting glucose level.
METHODS: The large-scale, community-based, cross-sectional study was conducted in 2012 in Ilam province, Iran, and comprised 150 impaired fasting glucose cases and 450 controls. Face-to-face interviews were conducted using a standard lifestyle questionnaire, and subjects were checked for fasting plasma glucose. Chi-square test and multivariate logistic regression were used for statistical analysis.
RESULTS: Of the 600 participants, 172 (28.7%) were males and 428 (71.3%) were females. Their ages ranged from 20 to 83 years with a mean of 48.9 +/- 14.2 years for the cases and 45.5 +/- 13.4 years for the controls (p < 0.008). There was no statistically significant difference in terms of age, gender, marital status, location, family history of diabetes and body mass index in the two groups (p > 0.05). Using multivariate logistic regression, ghee consumption increased the risk of impaired fasting glucose up to 2.2 folds (Odds Ratio = 1.28, 95% Confidence Interval: 0.75-2.2); inactivity up to 2.33 folds (Odds Ratio = 1.33, 95% Confidence Interval: 0.75-2.33) and smoking up to 3.13 folds (Odds Ratio = 1.46, 95% Confidence Interval: 0.68-3.13). The differences were not statistically significant.
CONCLUSION: Risk of impaired fasting glucose increases with lifestyle risk factors that need to be considered seriously by policy makers.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25252522

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  1 in total

1.  The Association of Age and Gender with Risk Factors of Noncommunicable Diseases among Employees in West of Iran.

Authors:  Nahid Khademi; Mehran Babanejad; Atefeh Asadmobini; Hossein Karim
Journal:  Int J Prev Med       Date:  2017-02-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.